This page lists 5 immunotherapy doctors in Bengaluru, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Immunotherapy doctors in Bengaluru, India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
Immunotherapy doctors
FeaturedDr. Kirankumar Sajjanshetty
- 10+ years of experience in Medical Oncologist
- Consultant — Medical Oncology at Gleneagles Hospitals, Bengaluru, Present
- Chemotherapy Administration and Infusion Management
- Cancer Immunotherapy and Checkpoint Inhibitor Therapy
- Molecular Targeted Therapy Planning
- Hormone Therapy for Breast and Gynaecologic Cancers
- Hematologic Malignancy Management
Dr. Rajeev Vijayakumar
- 20+ years of experience in Medical Oncologist
- Head of Department & Senior Consultant – Medical Oncology, Gleneagles Hospitals, Bengaluru
- Senior Consultant – Hemato-Oncology and Bone Marrow Transplant, Gleneagles Hospitals, Bengaluru
- Chemotherapy administration and management
- Targeted molecular therapy
- Cancer immunotherapy and immune checkpoint inhibitors
- CAR-T cell therapy
- Bone marrow transplantation
Dr. Sangeetha K P
- 11+ years of experience in Medical Oncologist
- Consultant, Medical Oncology — Apollo Hospitals, Bannerghatta Road, Bengaluru — 11+ years
- Advanced Palliative Care training — India
- Adjuvant chemotherapy for solid tumours
- Neoadjuvant chemotherapy protocols
- Palliative chemotherapy management
- Immunotherapy with checkpoint inhibitors
- Targeted molecular therapy
Dr. Sireesh Kumar Ch
- 4+ years of experience in Medical Oncologist
- Consultant Medical Oncology — Apollo Hospitals, Bannerghatta Road, Bengaluru, Present
- Medical Oncology Training — Aster MIMS, Calicut
- Chemotherapy Administration
- Immunotherapy and Checkpoint Inhibitors
- Molecular Targeted Therapy
- Hormone Therapy Management
- Palliative Cancer Care
Dr. Vijay Agarwal
- 19+ years of experience in Medical Oncologist
- Consultant, Medical Oncology — Apollo Hospitals, Bannerghatta Road, Bengaluru, India (Present)
- Senior Oncology Clinician — Specialized in multimodal cancer treatment across solid and hematologic malignancies
- Chemotherapy administration for solid tumors
- Adjuvant chemotherapy protocols
- Neoadjuvant chemotherapy planning
- Immunotherapy and checkpoint inhibitor therapy
- Molecular targeted therapy
Hospitals where these doctors practise
🇮🇳 Bangalore, IndiaApollo Hospital, Bannerghatta Road
Why consider treatment in India?
Many international patients consider India for multiple myeloma treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
What is Immunotherapy?
Immunotherapy uses drugs that help the patient's own immune system recognize and destroy cancer cells, and is used across many cancers including breast, lung, colorectal, gastric/esophageal, liver/pancreatic, ovarian/gynaecological, head & neck cancers, leukemia, lymphoma, and multiple myeloma. It is given as an infusion in cycles, either alone or combined with chemotherapy/targeted therapy, and India offers globally approved immunotherapy drugs and advanced options like CAR-T cell therapy at a fraction of Western costs. Treatment plans are individualized based on tumor type, biomarker status (e.g., PD-L1, MSI), and stage of disease.
Who may be considered?
Immunotherapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.
How does it work?
Drugs such as PD-1/PD-L1 and CTLA-4 inhibitors are given as IV infusions every 2-4 weeks to block signals that let cancer cells evade the immune system, often combined with chemotherapy for greater effect.
Immune Checkpoint Inhibitor Therapy
Most CommonDrugs such as PD-1/PD-L1 and CTLA-4 inhibitors are given as IV infusions every 2-4 weeks to block signals that let cancer cells evade the immune system, often combined with chemotherapy for greater effect.
Comprehensive Investigations
CBC, liver and kidney function tests, thyroid function tests, PD-L1/MSI/biomarker testing, contrast CT/PET-CT, ECG, tumor board review
Treatment / Procedure Estimate
Stay in India
Usually Included in Hospital Package
- Oncologist consultations
- Day-care infusion facility
- Drug administration and monitoring
- Pre-cycle blood work
- Nursing care during infusion
Usually Not Included
- Cost of immunotherapy drug (billed per cycle)
- Interim PET-CT/imaging for response assessment
- Management of immune-related side effects if hospitalization needed
- Genetic/biomarker testing not covered under package
Recovery and follow-up
Most patients tolerate immunotherapy infusions as outpatients and can resume light activity within a day or two, though fatigue, skin rash, or flu-like symptoms are common and are monitored through regular blood tests before each cycle. CAR-T patients require a longer inpatient recovery period with close monitoring for delayed immune reactions.
Risks
Immunotherapy can trigger immune-related side effects affecting the skin, gut, lungs, liver, or endocrine glands, and rarely severe reactions like cytokine release syndrome (especially with CAR-T) that require prompt hospital management. Response to treatment varies by tumor type and biomarker status, and not all patients achieve remission.
Alternatives
Depending on the cancer type and stage, alternatives include conventional chemotherapy, targeted therapy, radiation therapy, hormonal therapy, surgery, or a combination approach as advised by the tumor board.
What we need to prepare a formal estimate
Share whatever you have — the care team will confirm the final checklist after reviewing your case.
Reports required
- Histopathology and biopsy report confirming cancer type
- Biomarker/genetic testing results (PD-L1, HER2, MSI, EGFR, etc.)
- Recent CT/PET-CT/MRI imaging reports
- Complete blood count and liver/kidney function tests
- Previous chemotherapy/radiotherapy/surgery records
- Bone marrow biopsy report (for blood cancers)
- Cardiac evaluation report (ECG/ECHO)
- Discharge summaries from previous hospitalizations
Patient information needed
- Current age, weight, and general performance status
- Detailed cancer diagnosis with stage and biomarker status
- History of prior treatments and response to them
- Any known drug allergies or autoimmune conditions
- Current medications including steroids or immunosuppressants
- Presence of other chronic conditions (diabetes, heart or lung disease)
- Availability of a caregiver/attendant during treatment
- Preferred treatment start date and travel flexibility
Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.
How this directory is built
Doctors are matched using the specialty, location, condition (Immunotherapy) and procedure (Immunotherapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.